A History of Cancer Chemotherapy.¶
DeVita, V. T., & Chu, E. (2008). A History of Cancer Chemotherapy. Cancer Research, 68(21), 8643-8653.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Intervention-Coupled Harm
- For coupled harms, the combination move exploits that if mechanism A yields benefit with harm signature H_A and mechanism B yields benefit with harm signature H_B, combining at sub-maximal doses can achieve full benefit while keeping each harm signature below threshold — used in combination chemotherapy, defence-in-depth, and combination antibiotics.
This sourceEstablishes that cytotoxic chemotherapy kills rapidly dividing cancer cells and rapidly dividing normal cells (marrow, gut, follicles) by the identical division-targeting mechanism, and the rationale for combination chemotherapy at sub-maximal doses.
- For coupled harms, the combination move exploits that if mechanism A yields benefit with harm signature H_A and mechanism B yields benefit with harm signature H_B, combining at sub-maximal doses can achieve full benefit while keeping each harm signature below threshold — used in combination chemotherapy, defence-in-depth, and combination antibiotics.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:982164f135ff · see in the full table